According to Zacks, “Agiliti Inc. is an essential service provider to the healthcare industry. It offer medical equipment management and service solutions. Agiliti Inc. is based in MINNEAPOLIS. “
A number of other analysts have also recently commented on AGTI. Raymond James cut their target price on Agiliti from $30.00 to $25.00 and set an “outperform” rating on the stock in a research report on Friday, March 11th. Citigroup cut their target price on Agiliti from $28.00 to $25.00 and set a “buy” rating on the stock in a research report on Wednesday, March 9th. The Goldman Sachs Group dropped their price target on Agiliti from $32.00 to $28.00 and set a “buy” rating on the stock in a research report on Friday, March 11th. Morgan Stanley dropped their price target on Agiliti from $30.00 to $24.00 and set an “overweight” rating on the stock in a research report on Thursday, March 10th. Finally, BMO Capital Markets boosted their price target on Agiliti from $22.00 to $28.00 and gave the company an “outperform” rating in a research report on Wednesday, April 6th. Two research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $23.00.
Agiliti (NYSE:AGTI – Get Rating) last posted its earnings results on Tuesday, March 8th. The company reported $0.23 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.04. Agiliti had a return on equity of 15.02% and a net margin of 2.31%. The business had revenue of $290.48 million for the quarter, compared to analysts’ expectations of $268.54 million. Research analysts forecast that Agiliti will post 0.85 EPS for the current fiscal year.
In related news, EVP Lee M. Neumann sold 10,042 shares of the stock in a transaction dated Friday, February 18th. The shares were sold at an average price of $17.96, for a total transaction of $180,354.32. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Bettyann Bird sold 15,000 shares of the stock in a transaction dated Wednesday, March 2nd. The stock was sold at an average price of $18.51, for a total transaction of $277,650.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 152,489 shares of company stock valued at $2,859,488. 4.16% of the stock is currently owned by corporate insiders.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Cornercap Investment Counsel Inc. increased its stake in shares of Agiliti by 19.8% in the first quarter. Cornercap Investment Counsel Inc. now owns 62,256 shares of the company’s stock valued at $1,314,000 after purchasing an additional 10,269 shares during the period. Swiss National Bank increased its stake in shares of Agiliti by 7.7% in the first quarter. Swiss National Bank now owns 77,300 shares of the company’s stock valued at $1,631,000 after purchasing an additional 5,500 shares during the period. New York State Common Retirement Fund increased its stake in shares of Agiliti by 19.9% in the first quarter. New York State Common Retirement Fund now owns 17,610 shares of the company’s stock valued at $372,000 after purchasing an additional 2,925 shares during the period. Victory Capital Management Inc. acquired a new stake in shares of Agiliti in the first quarter valued at approximately $243,000. Finally, Shell Asset Management Co. increased its stake in shares of Agiliti by 76.0% in the first quarter. Shell Asset Management Co. now owns 13,324 shares of the company’s stock valued at $281,000 after purchasing an additional 5,754 shares during the period. Hedge funds and other institutional investors own 99.27% of the company’s stock.
Agiliti Company Profile (Get Rating)
Agiliti, Inc provides healthcare technology management and service solutions to the healthcare industry in the United States. The company offers onsite managed services, including programs for the management, reprocessing, and logistics of medical equipment at individual facilities and integrated delivery networks to monitor and adjust equipment quantities and availability to address fluctuations in patient census and acuity.
- Get a free copy of the StockNews.com research report on Agiliti (AGTI)
- If PetMeds Is A Good Buy There Will Be A Better Signal
- Insiders Buy Occidental Petroleum Ahead Of Q1 Earnings
- High-Yield Deep-Value LCI Industries Exceeds All Expectations
- Shopify (NYSE: SHOP) Approaches Key Support Level
- Follow The Money To Cigna
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Agiliti Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agiliti and related companies with MarketBeat.com's FREE daily email newsletter.